Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.407NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.407NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.423NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.423NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.281NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.281NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.281NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.230NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.230NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.230NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.535NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.535NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.535NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.564.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.564.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.564.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.345NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.345NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.345NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.450NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.450NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.334NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.334NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.334NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.589NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.589NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.589NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.335NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used